Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus

BACKGROUND: It is unknown whether canagliflozin, a selective sodium glucose co-transporter 2 inhibitor, reduces epicardial adipose tissue (EAT) thickness, which is associated with insulin resistance and is a risk factor for coronary artery disease. METHODS AND RESULTS: We administered 100 mg of cana...

Descripción completa

Detalles Bibliográficos
Autores principales: Yagi, Shusuke, Hirata, Yukina, Ise, Takayuki, Kusunose, Kenya, Yamada, Hirotsugu, Fukuda, Daiju, Salim, Hotimah Masdan, Maimaituxun, Gulinu, Nishio, Susumu, Takagawa, Yuriko, Hama, Saori, Matsuura, Tomomi, Yamaguchi, Koji, Tobiume, Takeshi, Soeki, Takeshi, Wakatsuki, Tetsuzo, Aihara, Ken-ichi, Akaike, Masashi, Shimabukuro, Michio, Sata, Masataka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628447/
https://www.ncbi.nlm.nih.gov/pubmed/29034006
http://dx.doi.org/10.1186/s13098-017-0275-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628447/
https://www.ncbi.nlm.nih.gov/pubmed/29034006
http://dx.doi.org/10.1186/s13098-017-0275-4

Ejemplares similares